CANVIRCEPT
UNII GRP8T9S9Y5

Substance Identification & Data

This profile provides standardized clinical and technical data for Canvircept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GRP8T9S9Y5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2833647-10-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
GRP8T9S9Y5
CAS Registry Number
2833647-10-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CANVIRCEPT
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C203183
National Cancer Institute reference terminology for clinical and research data.
INN ID
12882
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Canvircept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CANVIRCEPT

Common Names & Synonyms

ANGIOTENSIN-CONVERTING ENZYME 2 (355-ASPARAGINE,359-ASPARAGINE) (HUMAN EXTRACELLULAR DOMAIN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN CH2-CH3 REGION) FUSION PROTEIN WITH IMMUNOGLOBULIN M (HUMAN C-TERMINAL TAIL FRAGMENT), DIMER, PENTAMER
CANVIRCEPT [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus